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Minor salivary gland tumors (benign and malignant) are rare, but are a potential ditagnosis for many lesions in the oral cavity, 
especially lesions arising from the hard palate.1 Salivary 
gland neoplasms represent 3% to 5% of all head and 
neck neoplasms, with the incidence of malignancy 
varying by primary site of origin. Malignant tumors 
of the minor salivary glands constitute less than 0.5% 
of all malignant neoplasms.2 Whereas 14% to 22% of 
all salivary gland tumors are carcinomas,1 the majority 
of tumors arising from the minor salivary glands are 
malignant, unlike parotid and submandibular salivary 
glands tumors.1 We analyzed this group of tumors in 
our population in Northern Pakistan (AFIP).
Malignant tumors of the minor salivary glands 
in northern Pakistan: a clinicopathological 
study 
BACKGROUND: malignant tumors of the minor salivary glands comprise a small but significant proportion of 
oral cancers. We analyzed this group of tumors in our population.
METHODS: the records of all cases of malignant minor salivary gland tumors diagnosed at the armed forces 
institute of pathology (afip), rawalpindi, pakistan, during a period of 10 years (1994-2003) are described. the 
institute receives biopsy material from armed forces and public and private sector hospitals in northern pakistan 
as well as referrals for second opinion.
RESULTS: a total of 21 168 tumors were recorded at the afip tumor registry during the study period. these 
included 70 malignant minor salivary gland tumors. twenty-three of these (32.8%) arose in the palate while 
the remaining tumors originated at other sites in the oral cavity. the commonest histological type was adenoid 
cystic carcinoma, constituting 30 cases (42.8%). the next most common type was mucoepidermoid carcinoma 
comprising 26 (37.1%) cases. the mean age of cases was 43.4 years and the male-to-female ratio was 1:1.4. 
there were 2 cases each of polymorphous low-grade adenocarcinoma and clear cell adenocarcinoma. the 
remaining cases included undifferentiated carcinomas, adenocarcinomas (not otherwise specified) and a few 
other rare tumors.
CONCLUSION: adenoid cystic carcinoma was the commonest malignant neoplasm of the minor salivary glands 
followed by mucoepidermoid carcinoma. the palate was the commonest location of these tumors.
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METHODS
The records of all cases of malignant minor salivary 
gland tumors diagnosed at the Armed Forces Institute 
of Pathology (AFIP), Rawalpindi, during a period of 
10 years (1994t2003) were retrieved from the files. 
This institute receives biopsy material from armed 
forces, public and private sector hospitals in northern 
Pakistan as well as referrals for second opinion. The 
data was analyzed according to histological type and 
site. Cases were reevaluated and analyzed by the cont
sultant and where necessary were reclassified according 
to the WHO classification. Immunohistochemical ant
tibodies like CK AE1/AE3, smooth muscle actin, cart
cinoembryonic antigen, St100, and CD117 were used 
for confirmation of the diagnosis. The data were then 
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analyzed and the frequencies of various subtypes of the 
salivary gland tumors then compared with the frequent
cies of salivary gland tumors in western studies by the 
chitsquare test.
RESULTS 
A total of 21 168 malignant tumors were recorded at the 
AFIP Tumor Registry during the study period. These 
included 70 (0.3%) malignant minor salivary gland 
tumors. The most frequent tumor was adenoid cystic 
carcinoma followed by mucoepidermoid carcinoma, adt
enocarcinoma (not otherwise specified), polymorphous 
lowtgrade adenocarcinoma and clear cell carcinoma 
(Table 1).
The ages of patients ranged from 18 to 78 years. The 
mean age was 47 years and the malettotfemale ratio was 
1:1.4. The most common site for tumors was the palt
ate (32.8%) (Figure 1). The exact site was known in 41 
cases. The commonest histological type was adenoid 
cystic carcinoma, constituting 30 cases (42.8%). The 
gender distribution was 18 males and 12 females. The 
ages ranged from 20 to 78 years. The mean age was 49 
years and the malettotfemale ratio was 1.5:1. The tumor 
distribution for adenoid cystiic carcinoma according to 
site is shown in Figure 2. In nine cases the exact site was 
not known. The next most common type was mucoepit
dermoid carcinoma comprising 26 (37.1%) cases. The 
gender distribution was 11 males and 15 females. The 
malettotfemale ratio was 1:1.4. The ages ranged from 
18 to 67 years, while the mean age was 43.4 years. The 
tumor distribution for mucoepidermal carcinoma act
cording to site is shown in Figure 3. There were two 
cases each of polymorphous lowtgrade adenocarcinoma 
(2.8%). The primary tumor site was the hard palate. 
There were two cases of clear cell adenocarcinoma. The 
primary tumor sites were lower lip and oral mucosa. In 
the statistical comparison with other studies, we found 
no significant differences in the frequencies of salivary 
gland tumors.
DISCUSSION
Tumors of the minor salivary glands constitute a hett
erogeneous group of neoplasms originating from the 
proliferation of different precursor cells.2 Many occur 
within the oral cavity, although origination from other 
sites in the upper aerodigestive tract, such as the orot
pharynx, nasal cavity and paranasal sinuses is reported. 
The etiology is unknown and unlike squamous cell 
carcinoma is not related to smoking.1 Significant dift
ferences in the percentage of malignancy and the relat
tive frequency of various tumors are noted for different 
sites. Almost 50 percent of tumors of the palate and 
buccal mucosa are malignant, which is similar to the 
overall prevalence of malignancy in all minor salivary 
gland sites combined.3 
The sex distribution of the minor salivary gland 
neoplasms differs by report. Studies from India2 and 
Libya4 show contrasting results as the former show 
a male predominance with a malettotfemale ratio of 
1.4:1 in contrast to the latter in which the malettotfet
male ratio is 1.4:2. A study from the USA reports a 
slight female predominance.3 Our study also shows a 
slight overall female predominance.
Studies from Asia and Africa report malignant mit
nor salivary gland tumors as more common in younger 
age groups, mostly the fifth decade of life2,4,7 as comt
pared to western studies, where the tumors are found 
in older age groups, predominantly in the seventh det
palate (56%, n=23)
Tongue (10%, n=4)
lower lip (7%, n=3)
upper lip (5%, n=2)
Tonsil (5%, n=2)
Floor of mouth (10%, n=4)
pharynx (7%, n=3) 
Table 1: Distribution of malignant minor salivary gland tumors according to histological 
types (n=70).
Histological  Types n=70 %
Adenoid cystic carcinoma 30 42.9
Mucoepidermoid carcinoma 26 37.1
Adenocarcinoma nOS 3 4.2
polymorphous low grade 2 2.9
Clear cell carcinoma 2 2.9
undifferentiated carcinomas 3 4.2
epithelial myoepitheial carcinomas  2 2.9
Carcinoma ex pleomorphic adenoma                            2 2.9
Total 70 100
nOS=not otherwise specified
FIgure 1. Distribution of tumors according to sites (n=41).
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palate (56%, n=12)
Floor of mouth (5%, n=1)
lower lip (10%, n=2)
upper lip (5%, n=1)
Tonsil (5%, n=1)
pharynx (10%, n=2)
Tongue (10%, n=2) 
Hard palate (51%, n=6)
base of tongue (17%, n=2)
Tongue (8%, n=1)
palatine tonsil (8%, n=1)
labio buccal mucosa 
(8%, n=1)
preiepiglottic  (10%, n=4)
Figure 2. Distribution of adenoid cystic carcinoma according to anatomical site (n=21).
Figure 3. Distribution of mucoepidermoid carcinoma according to site (n=12).
cade.1,11 Our study also shows an age distribution simit
lar to reports from Asia and Africa. This may reflect 
the overall demographic makeup of our population. 
The principal site of involvement by malignant mit
nor salivary gland tumors in our study was found to 
be the palate, which corresponds to various studies 
reported worldwide.1,2,4,7,9t11 In our study, the second 
commonest site was the tongue, which is similar to that 
reported by Pandey et al from India,2 but is in contrast 
to studies reported from Libya4 and the UK9 where the 
buccal mucosa and lips were found to be the second 
commonest site, respectively .
There is a variation in the prevalence of the spet
cific types of minor salivary gland tumors worldwide. 
Different studies from same regions of the world show 
variable results, some showing adenoid cystic carcinot
ma to be the commonest tumor1,8,9,13,15t20 while others 
show mucoepidermoid carcinoma as the predominant 
tumor.2,3,10t12,21t25 In our study, although adenoid cystic 
carcinoma was the commonest and mucoepidermoid 
the second commonest tumor, the difference between 
the number of the two tumors does not seem to be of 
any significance. We compared our results with other 
studies by applying the chitsquare test and calculating 
a P value, but the results showed no significant findt
ing. In most studies from the western world including 
Australia,1 UK,8 USA,9,15t20 and Denmark,13 adenoid 
cystic carcinoma was the most prevalent malignant 
neoplasm followed by mucoepidermoid carcinoma, as 
in our study. In studies from India,2 Japan,10 the UK,12 
Australia22 and the USA,3,11,21,23t25 mucoepidermoid 
carcinoma predominates, followed by adenoid cystic 
carcinoma, followed by adenocarcinomas. In a study 
from Israel by Nagler,14 adenocarcinoma was reported 
as the most common, but this study was not comparat
ble as further classification of the tumors was not done. 
On the other hand, a study in an African population by 
Van Heerden reports the most common malignant tut
mor to be polymorphous lowtgrade adenocarcinoma7 
in contrast to our study in which only two cases were 
reported in the span of ten years. This may reflect a 
peculiar genetic predisposition to the tumor. This obt
servation needs further investigation.
 In conclusion, adenoid cystic carcinoma was found 
to be the commonest malignant neoplasm of the mit
nor salivary gland followed by mucoepidermoid carcit
noma. The palate was the commonest location of these 
tumors. Female patients were more commonly affected 
overall. Males were more commonly affected than fet
males by adenoid cystic carcinoma.
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